---
figid: PMC6580124__OTT-12-4643-g0008
figtitle: Mechanism of rapamycin’s anti-angiogenic and anti-lymphangiogenic effects
  in melanoma
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC6580124
filename: OTT-12-4643-g0008.jpg
figlink: /pmc/articles/PMC6580124/figure/F0007/
number: F7
caption: Potential mechanism of rapamycin’s anti-angiogenic and anti-lymphangiogenic
  effects in melanoma. Rapamycin blocks the mTOR signaling pathway in melanoma cells
  and leads to the decrease of the secretion of VEGF-A and VEGF-C. Rapamycin also
  blocks the mTOR signaling pathway in ECs or LECs and leads to the decrease of the
  expression of VEGFR-2 and VEGFR-3. Therefore, inhibition of both the VEGF-A/VEGFR-2
  axis and the VEGF-C/VEGFR-3 axis results in the suppressed angiogenesis and lymphangiogenesis
  in the tumor.
papertitle: Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by
  downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression.
reftext: Min Wang, et al. Onco Targets Ther. 2019;12:4643-4654.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9682253
figid_alias: PMC6580124__F7
figtype: Figure
redirect_from: /figures/PMC6580124__F7
ndex: 8d01c6f0-decc-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6580124__OTT-12-4643-g0008.html
  '@type': Dataset
  description: Potential mechanism of rapamycin’s anti-angiogenic and anti-lymphangiogenic
    effects in melanoma. Rapamycin blocks the mTOR signaling pathway in melanoma cells
    and leads to the decrease of the secretion of VEGF-A and VEGF-C. Rapamycin also
    blocks the mTOR signaling pathway in ECs or LECs and leads to the decrease of
    the expression of VEGFR-2 and VEGFR-3. Therefore, inhibition of both the VEGF-A/VEGFR-2
    axis and the VEGF-C/VEGFR-3 axis results in the suppressed angiogenesis and lymphangiogenesis
    in the tumor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPS6KB1
  - EIF4EBP1
  - VEGFC
  - VEGFD
  - VEGFA
  - FLT4
  - KDR
  - CCL16
  - Rapamycin
  - Melanoma
---
